Prosperity Organic Foods Inc., based in Idaho, has recalled roughly 1,304 cases of Miyoko's Creamery European style salted plant milk butter after testing raised concerns about mold, E. coli and yeast contamination. The U.S. Food and Drug Administration classified the action as a Class II recall on Oct. 23, though the company initiated it in early September.
What Triggered the Recall
According to the FDA, the recall involves an 8-ounce plant-based butter product packaged six to a case, under lot number 07871, with a best-by date of Nov. 5, 2026. The agency's Class II designation indicates that exposure to the affected product could cause temporary or medically reversible health effects, or that the likelihood of serious harm is low. The FDA has not detailed how the contamination was discovered or how many illnesses, if any, have been reported.
Where the Product Was Sold
The affected cases were distributed to retailers in ten states: Illinois, Indiana, Wisconsin, Connecticut, Florida, Georgia, Iowa, Maryland, New Jersey and New Hampshire. Consumers who purchased Miyoko's Creamery European style salted plant milk butter in these states are advised to check the lot number and expiration date printed on the package before use.
What Consumers Should Do
Federal food-safety guidance generally recommends that shoppers who have purchased a recalled product avoid consuming it and either discard it or return it to the place of purchase for a refund. Those who experience gastrointestinal symptoms after eating a recalled item are typically advised to contact a health care provider, particularly if symptoms are severe or persistent. The full recall notice, including contact information for the manufacturer, is available through the FDA's recall database.
Why Classification Matters
The FDA sorts recalls into three classes based on risk severity: Class I involves a reasonable probability of serious health consequences or death; Class II, as in this case, involves a remote probability of serious harm or the possibility of temporary, reversible effects; and Class III involves products unlikely to cause any adverse health consequences. This classification helps consumers and regulators gauge urgency, though it does not eliminate the need for anyone with symptoms to seek medical guidance.